1700 Minor Ave Suite 1600, Seattle, WA 98101
pamela.a.shaw@kp.org
Home
PI
About
Research
Publications
Book
Shaw Lab
About
People
(Sh)
2
Collaborative
About
People
Research
Publications
Software
News
Contact
Search
Infectious Disease
Marques A, Telford SR, Turk S, Chung E, Williams C, Dardick K, Krause P, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi infection: A first-in-human study. Clinical Infectious Diseases, 2014: 58(7), 937-945.
March 29, 2021
Olivier KN, Shaw PA, Glaser TS, Bhattacharyya D, Fleshner M, Brewer CC, Zalewski CK, Folio LR, Seigelman JR, Shallom S, Park IK, Sampaio EP Zelazny AM, Holland SM, Prevots DR. Inhaled amikacin for treatment refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014 Jan; 11(1):30-5.
March 29, 2021
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
March 29, 2021
Memoli JJ, Czajkowski L, Reed S, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Taubenberger JK. Validation of a Wild-Type Influenza A Human Challenge Model: H1N1pdMIST, An A(H1N1)pdm09 Dose Finding IND Study. Clinical Infectious Diseases, 2015; 60(5): 693-702.
March 29, 2021
Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT, Taubenberger JK. : Evaluation of Anti-Hemagglutinin and Anti-Neuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model. mBio April 2016; 7(2) doi: 10.1128/mBio.00417-16.
March 29, 2021
Fleshner M, Olivier KN, Shaw PA, Adjemian J, Strollo S, Claypool RJ, Folio L, Zelazny A, Holland SM Prevots DR.: Mortality among Patients with Pulmonary Nontuberculous Mycobacterial Disease. International Journal of TB and Lung Disease, 2016 May; 20(5): 582-587.
March 29, 2021
Gowda C, Brown T, Compher C, Forde K, Kostman J, Shaw PA, Tien P, Lo Re V: Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection. AIDS, 2016 Oct 23; 30(16):2519-2528.
March 29, 2021
Gowda C, Coppock D, Brickman C, Shaw PA, Gross R.: Determinants of HIV Transmission Risk Among HIV-Infected Persons Engaged in Care. AIDS Education and Prevention, 2016 Oct; 28(5):440-452.
March 29, 2021
Kushner T, Shaw PA, Kalra A, Magaldi L, Monpara P, Bedi G, Krok K, Centkowski S, Dalldorf K, D’souza J, Halegoua-De Marzio D, Goldberg DS, Trooskin S, Levine LD, Srinivas SK, Lewis JD, Forde KA, Lo Re V 3rd: Incidence, determinants and outcomes of pregnancy-associated hepatitis B flares: A regional hospital-based cohort study. Liver International 38(5): 813-20, May 2018.
March 29, 2021
Steytler J, Shaw PA, Pau AK, Khabo P, Joshi G, Oelofse P, and Phidisa 2 Study Team. Analysis of Site Heterogeneity and HIV Outcomes Across Rural and Urban Study Sites in Phidisa II – A Multi-site Randomized Controlled Antiretroviral Treatment Trial in a South African Military Cohort. Current HIV Research 2017 May;15(3):178-187.
March 29, 2021
1
2
3